Australia Antimicrobial Susceptibility Testing Market (2024-2029)
The Australia Antimicrobial Susceptibility Testing Market was valued at $84.7 Million in 2024 and projected to reach to $106.1 Million by 2029, representing a compound annual growth rate of CAGR 4.6%. Australia's antimicrobial susceptibility testing market is positioned for steady growth through 2029, driven by escalating antimicrobial resistance concerns and regulatory emphasis on infection control.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Antimicrobial Susceptibility Testing Market Trends and Insights
- Australia's healthcare infrastructure and rising antimicrobial resistance concerns are driving demand for advanced diagnostic solutions across pathology laboratories and clinical settings.
- The market in Australia reflects increasing adoption of automated testing platforms and molecular diagnostic technologies to combat growing resistance patterns in bacterial infections..
Key Market Statistics
- CAGR (2024-2029) CAGR 4.6%
- Market Size, 2024 ~USD 84.7 Million
- Forecast, 2029 ~USD 106.1 Million
- Country Australia
Australia Antimicrobial Susceptibility Testing Market Overview
Market Valuation :
Australia's antimicrobial susceptibility testing market reached $84.7 million in 2024, with steady growth trajectory driven by healthcare modernization and diagnostic advancement across the region.
Rising Antimicrobial Resistance :
Increasing prevalence of antibiotic-resistant pathogens in Australian healthcare facilities is accelerating adoption of rapid and accurate susceptibility testing solutions in pathology laboratories.
Healthcare Infrastructure Investment :
Australia's robust healthcare system and investment in diagnostic capabilities are supporting demand for advanced AST technologies across public and private clinical settings nationwide.
Growth Momentum :
Projected to reach $106.1 million by 2029 at a 4.6% CAGR, Australia's market demonstrates consistent expansion slightly below the global 5% rate, reflecting regional healthcare priorities.
Australia Antimicrobial Susceptibility Testing Market Dynamics
- Healthcare providers across major cities and regional centers are increasingly adopting automated and rapid AST platforms to improve patient outcomes and reduce treatment delays.
- The market benefits from Australia's advanced healthcare infrastructure, strong pathology laboratory networks, and government initiatives addressing antibiotic stewardship.
- Continued investment in diagnostic technologies and rising awareness among clinicians will sustain market expansion.
- However, growth remains measured compared to global rates, reflecting market maturity and competitive pricing pressures in the Australian healthcare sector..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Australia's antimicrobial susceptibility testing market is valued at $84.7 million in 2024 with projected growth to $106.1 million by 2029.
- Australia demonstrates a 4.6% CAGR, driven by rising antimicrobial resistance and healthcare modernization initiatives.
- Australia's market growth is supported by increased laboratory automation and adoption of rapid diagnostic technologies.
- Australia's regulatory environment and infection control standards are key factors accelerating market expansion through 2029.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
Australia Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers of AST platforms and laboratory automation systems need Australia-specific market data to assess market opportunity, competitive positioning, and localization strategies for pathology labs.
- Pathology Laboratory Networks : Major pathology providers and laboratory operators require market insights to evaluate technology investments, benchmark performance against peers, and align with antimicrobial stewardship initiatives.
- Healthcare Consultants & Advisors : Consulting firms advising healthcare organizations, private equity investors, and medical device companies need Australia-specific market intelligence to support due diligence and strategic recommendations.
- Hospital & Clinical Administrators : Hospital procurement teams and clinical laboratory directors need market data to justify capital expenditures, evaluate vendor options, and optimize diagnostic workflows for infection control.
- Investment & Private Equity Firms : Investors evaluating opportunities in Australian healthcare diagnostics require detailed market analysis, growth projections, and competitive dynamics to assess portfolio companies and acquisition targets.
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for Australia's AST market ($84.7M in 2024, $106.1M by 2029) with country-specific CAGR analysis to inform investment and expansion decisions.
- Antimicrobial Resistance Insights : Understand Australia-specific AMR trends, regulatory drivers, and clinical adoption patterns shaping demand for susceptibility testing across pathology networks and hospital laboratories.
- Competitive Landscape Analysis : Identify key players, market consolidation trends, and competitive positioning within Australia's healthcare diagnostics sector to benchmark performance and identify partnership opportunities.
- Healthcare Infrastructure Context : Leverage insights into Australia's pathology laboratory ecosystem, public-private healthcare dynamics, and diagnostic technology adoption rates to tailor market entry and growth strategies.
- Strategic Planning & Risk Assessment : Evaluate market maturity, pricing pressures, regulatory environment, and growth constraints specific to Australia to develop informed business strategies and risk mitigation approaches.
Frequently asked questions
What is the current size of Australia's antimicrobial susceptibility testing market?
Australia's antimicrobial susceptibility testing market was valued at $84.7 million in 2024.
What is the projected market size for Australia by 2029?
Australia's antimicrobial susceptibility testing market is forecast to reach $106.1 million by 2029.
What is the CAGR for Australia's antimicrobial susceptibility testing market?
Australia's market is expected to grow at a compound annual growth rate of 4.6% from 2024 to 2029.
What factors are driving growth in Australia's antimicrobial susceptibility testing market?
Growth in Australia is driven by rising antimicrobial resistance, laboratory automation adoption, and strengthened infection control standards.
How does Australia's market compare to the Asia Pacific region?
Australia represents a significant segment within the Asia Pacific antimicrobial susceptibility testing market with steady growth momentum.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- US Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- UK Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- South Korea Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
